MDI-1228

N/A

Report date: 2026/03/03 15:39:15
NME

Base Information

Drug NameMDI-1228
Drug Alias NameMDI-1228_mesylateMDI-1228
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitors
TargetsJanus kinase
Therapy Area/IndicationsPropionibacterium acnes infectionAlopecia AreataDermatitis, Atopic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHenan Maiyingnuo Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhuhai Rui-Inno Pharmaceutical Technology Co LtdShanghai Medinno Pharmaceutical Technology Co LtdHenan Maiyingnuo Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsPropionibacterium acnes infectionAlopecia AreataDermatitis, Atopic +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A